Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Immunization program

From: Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice

Group Immunogen Dose Number of mice Immunization route
1 PBS 0 30 i.m.
2 rNP 10 μg 30 i.m.
3 rNP 30 μg 30 i.m.
4 rNP 90 μg 30 i.m.
5 RVJ1175NP 2×107 PFU 30 i.m.
  1. Note: Amino acid sequences of NP derived from A/Jingke/30/95(H3N2).